<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03088501</url>
  </required_header>
  <id_info>
    <org_study_id>LN0182</org_study_id>
    <nct_id>NCT03088501</nct_id>
  </id_info>
  <brief_title>Participant Engagement and Retention Trial in a Public Hospital (PERTH): An RCT Protocol</brief_title>
  <acronym>PERTH</acronym>
  <official_title>Participant Engagement and Retention Trial in a Public Hospital (PERTH): An RCT Protocol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Public Health Foundation of India</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Public Health Foundation of India</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      MAASTHI (Maternal Antecedents of Adiposity Studying the Transgenerational role of
      Hyperglycaemia and Insulin) is a prospective birth cohort with the aim of assessing the
      effects of glucose levels in pregnancy on the risk of adverse infant outcomes, especially in
      predicting the possible risk markers of later chronic diseases. The recruitment of the
      pregnant women in MAASTHI has begun in the month of April 2016. Of the eligible pregnant
      women only 77% completed the oral glucose tolerance tests.The follow ups of mother and child
      are conducted at birth and annually during the year 1, 2, 3 and 4 of the child. Despite
      stringent adherence of including only the residents of the source population, nearly 13% of
      the women were lost to follow-ups at birth. In order to prevent further loss to follow-ups in
      subsequent visits, the investigators aim to explore whether interventions involving
      innovative Interactive Voice Response System (IVRS) and conducting mother and baby workshops
      can improve in the number pf women undergoing lab tests and subsequent follow-ups.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Longitudinal cohort studies are important for the understanding of etiological mechanisms of
      underlying hypotheses. However, it is particularly challenging to sustain participation of
      subjects in follow up visits in birth cohorts, as the observation period spans over several
      years, making it vulnerable to lose tracking subjects for several reasons. These include
      change in location of residence and lack of interest in the later stages of the study. In
      India, the traditional practice of pregnant women leaving the study area to return to their
      maternal residence for delivery. Few groups belonging to ethnic minorities, with low family
      income or low education can be at higher risk of selective attrition. In the absence of high
      follow-up rate, the results from prospective cohort studies are can be biased. Such a bias
      can occur if the reason for the loss is related to the outcome under investigation. The
      cohort studies done in India have variable rates of loss to follow-up varying from, 14-82%.
      The barriers for retaining greater proportion of study participants can be due to several
      reasons. While a number of reviews have reported different ways of improving study
      participation, little is known about the effectiveness of specific retention strategies
      deployed in retention of mothers and infants in a birth cohort.

      The proportion of pregnant women turning up for regular antenatal health checkups is poor in
      India. This is due to several reasons including lack of awareness, lack of social support,
      long waiting time, financial constraints and fear of hospital care. Evidence suggests that
      maternal education, husband's education, marital status, availability, cost, household
      income, women's employment, media exposure and previous obstetric history affects uptake of
      antenatal care services. According to National Family Health Survey (NFHS) (2014-15), only
      55.5% of women in urban Bangalore had completed the required four antenatal care visits
      during pregnancy.

      MAASTHI (Maternal Antecedents of Adiposity Studying the Transgenerational role of
      Hyperglycaemia and Insulin) is a prospective birth cohort with the aim of assessing the
      effects of glucose levels in pregnancy on the risk of adverse infant outcomes, especially in
      predicting the possible risk markers of later chronic diseases. The recruitment of the
      pregnant women in MAASTHI has begun in the month of April 2016. Of the eligible pregnant
      women only 77% completed the oral glucose tolerance tests despite offering the test free of
      cost and repeated reminders by the research team to get tested for gestational diabetes.
      After completion of OGTT, the follow ups of mother and child are conducted at birth and
      annually during the year 1, 2, 3 and 4 of the child. Despite stringent adherence of including
      only the residents of the source population, nearly 13% of the women were lost to follow-ups
      at birth. These women delivered in a different hospital mostly due to obstetric
      complications. Currently around 80 participants are recruited per month, with completion of
      all their records, anthropometry measurements, and Oral Glucose Tolerance Test (OGTT). Once
      the OGTT is done between 24-32 weeks of gestation, there is no further opportunity to meet
      them again till the delivery. The duration without contact increases the likelihood for
      attrition of future follow-ups. In the intervening period of initial contact and follow-up's,
      it is important that the research staff constantly engage with the participants through
      innovative methods. In order to improve the number of women undergoing OGTT and follow-ups,
      an intervention trial will be carried out that examines the role of innovative 1) IVR and
      2)Mother and baby workshops during the intervening time period between baseline and
      follow-up.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2018</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Participants will be randomized into each arm on a 1:1:1, using a computer-generated randomization list. Written allocation of assignments will be sealed in individual, sequentially numbered, non-resealable, opaque envelopes that will be used to allocate to the targeted number of participants.Once the participant is assigned to the arm, their unique respondent Identification Number ID(RID) and the arm to which they are allocated are recorded by the research assistants</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>After meeting inclusion criteria, consenting to participate and completing a baseline questionnaire, participants will be immediately assigned to the randomized study arm by the RA who will open one of the sequentially numbered envelopes to determine allocation. Before opening the envelope, the Respondent ID number will be written on the envelope. The assignment schedule will be kept in a locked filing cabinet in the study coordinator's office at the Indian Institute of Public Health. Research staff and pregnant women cannot be blinded because the intervention requires their participation; however, the data analyst will be blinded to the study arm assignment.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>The primary outcome is the proportion of participants visiting the hospital for OGTT before 32 weeks of gestation.</measure>
    <time_frame>10 week</time_frame>
    <description>Successful follow-up assessment will be defined as completion of lab tests of mother within the designated time of 32 weeks of gestation. Response rate will be estimated as the number of women who complete lab tests done by research staff divided by the total number of women who completed 32 weeks of gestation. Loss to follow up rate will be measured as the number of women who missed lab tests divided by the total number of women who completed 32 weeks of gestation during the corresponding study time period in the study population. Time frame is calculated based on the start of the intervention at 22 week of gestation to the time when the mother's gestational age is 32 weeks, which is a total duration of 10 weeks.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The proportion of participants who successfully complete follow-up assessment within one week of delivery</measure>
    <time_frame>18 week</time_frame>
    <description>Those who successfully complete, follow-up assessment within one week of delivery. Successful follow-up assessment will be defined as completion of follow-up questionnaire and anthropometry within the designated time of one week from the date of delivery. Follow-up rate will be estimated as the numbers of follow ups done by research staff divided by the total number of eligible live births due in the corresponding time period in the study population. The loss to follow up rate will be measured as the number of missed follow-ups divided by the total number of eligible live births due in the corresponding time period in the study population. The time frame is calculated based on the start of the intervention at 22 weeks of gestation to 40 weeks at the time of delivery, which is the duration of 18 weeks.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The proportion of participants who successfully complete second follow-up assessment when the infant is 3.5 month old.</measure>
    <time_frame>32 week</time_frame>
    <description>Successful follow-up assessment will be defined as completion of follow-up questionnaire and anthropometry of mother and child within the designated time of 3.5 months Â±15 days since the date of birth. Follow-up rate will be estimated as the number of 3.5 months follows ups done by research staff divided by the total number of 3.5-month-old infants during the corresponding study time period in the study population. The loss to follow up rate will be measured as the number of missed follow-ups divided by the total number of 3.5-months-old infants during the corresponding study time period in the study population. The time frame is calculated based on the start of the intervention at 22 weeks of gestation to the time when the infant is 3.5 months old(14 weeks) which is a total duration of 32 weeks.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The secondary outcome involves cost-benefit analysis of the IVRS and MBA workshop</measure>
    <time_frame>40 week</time_frame>
    <description>An economic evaluation of the intervention package in improving successive health visits compared to a control group will be done. A cost-effectiveness analysis will be done by assessing the balance between costs of the intervention and effects of improved visits from a healthcare provision perspective. Costs for all separate actions and time used by all individual healthcare professionals will be mapped including the costs towards the workshop program, costs for the IVRS and all other materials. The costs involved in the intervention package and the benefits achieved will be compared with those of control arm.Time frame: cost effective analysis will be done within 8 weeks after the 3.5 month follow-up.(32 week+8 week=40 week)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">795</enrollment>
  <condition>Intervention Study</condition>
  <arm_group>
    <arm_group_label>Interactive Voice Response System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Through IVRS, women will receive a 2-3 minute call that informs them about their lab test, next follow-up visit, breastfeeding, introduction of solid foods, immunization, motor development, and sleep.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mother and Baby Affairs (MBA) workshops</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This will involve antenatal workshop and counselling for parents.
Brief talk by health professionals.
Role-plays</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Arm</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The participants in this group do not get any specific interventions but would receive standard instructions to attend follow-up.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Interactive voice response system</intervention_name>
    <description>IVR allows the pregnant women, their family members to interact with a computer system using a telephone.Through IVR, women receive a 2-3 minute call that reminds them of lab test, their next follow-up visit and also provides information on child care attendance, breastfeeding, introduction of solid foods, motor development, and sleep.</description>
    <arm_group_label>Interactive Voice Response System</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mother and baby affairs workshop</intervention_name>
    <description>Mother and baby affairs workshop will involve antenatal workshop and counseling for parents. The intervention will involve brief talk by health professionals, quiz activities, role-plays on personal hygiene, nutritional food, institutional delivery, precautions at the time of delivery, caring for the baby, feeding of colostrum, homemade baby food, immunization, and family planning measures.</description>
    <arm_group_label>Mother and Baby Affairs (MBA) workshops</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Pregnant women between 14 to 28 weeks of gestational age and those who plan to deliver in
        the study hospital and reside in the study location for the next five years. She must be
        able to speak Kannada, Hindi or English and should be willing to provide informed consent
        voluntarily. The participant must own or have sufficient access to a cell phone and should
        be able to operate a cell phone with a partner, relative, etc who stay with her.

        Exclusion Criteria:

          -  Diabetes or Hepatitis B infection;

          -  HIV positivity;

          -  Pregnant women of other gestational ages
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Giridhar R Babu, MBBS, MPH, PhD(UCLA)</last_name>
    <phone>080-23206124</phone>
    <email>giridhar@iiphh.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Deepa R, BSc, PGDACR</last_name>
    <phone>9611281549</phone>
    <email>deepa@iiphh.org</email>
  </overall_contact_backup>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 14, 2016</study_first_submitted>
  <study_first_submitted_qc>March 16, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 23, 2017</study_first_posted>
  <last_update_submitted>April 4, 2018</last_update_submitted>
  <last_update_submitted_qc>April 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Birth cohort, follow-up, IVRS</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There is no drug or device being tested. This trial involves testing out the behavioural intervention in comparison with phone based technology for interactive voice based response to increase the follow-up of pregnant women.</ipd_description>
  </patient_data>
  <study_docs>
    <study_doc>
      <doc_id>PMID: PMC5065083</doc_id>
      <doc_type>Protocol of the birth cohort</doc_type>
      <doc_url>https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-016-1088-4</doc_url>
      <doc_comment>The proposed randomized controlled trial is nested within the MAASTHI Birth cohort in order to improve the follow-up rates.</doc_comment>
    </study_doc>
  </study_docs>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

